Zoledronate synergises with imatinib mesylate to inhibit Ph<sup>+</sup> primary leukaemic cell growth
Hidekazu Segawa(Shiga University of Medical Science), Taira Maekawa(Kyoto University Hospital), Eri Kawata(Panasonic (Japan)), Oliver G. Ottmann(Cardiff University), Eishi Ashihara(Kyoto Pharmaceutical University), Asumi Yokota(Kyoto University), Yuri Kamitsuji(Panasonic (Japan)), Takeshi Yuasa(Japanese Foundation For Cancer Research), Kiyoshi Sato(Tokyo Medical and Dental University), Shinya Kimura(Saga University), Yoshihide Fujiyama(Shiga University of Medical Science), Junya Kuroda(Kyoto Prefectural University of Medicine)
Cited by 27
Related Papers
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
|Clinical Immunology|2003|491
Interleukin-22, a Member of the IL-10 Subfamily, Induces Inflammatory Responses in Colonic Subepithelial Myofibroblasts
|Gastroenterology|2005|477
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464